Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Nuvation Bio Inc (NYSE: NUVB)

 
NUVB Technical Analysis
5
As on 9th Jun 2023 NUVB STOCK Price closed @ 1.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.12 & Strong Sell for SHORT-TERM with Stoploss of 6.29 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

NUVBSTOCK Price

Open 1.72 Change Price %
High 1.73 1 Day -0.03 -1.73
Low 1.66 1 Week 0.08 4.94
Close 1.70 1 Month 0.11 6.92
Volume 283141 1 Year -6.97 -80.39
52 Week High 9.50 | 52 Week Low 1.56
 
NYSE USA Most Active Stocks
DDR 15.44 -4.46%
NIO 7.73 -0.77%
TWTR 53.70 0.66%
CVNA 19.07 -21.30%
BACA-U 302.00 0.67%
PLTR 15.02 -1.12%
F 13.74 1.18%
CS 0.89 1.14%
RPAI 13.15 -3.17%
AUY 5.85 -0.68%
 
NYSE USA Top Gainers Stocks
CND-WT 0.05 400.00%
APRN 8.95 67.29%
WEI 0.44 51.72%
MOTV 18.70 50.20%
SPAQ 9.20 42.41%
SPAQ 9.20 42.41%
IMPX 9.39 20.69%
BARK 1.37 20.18%
BARK 1.37 20.18%
PRTY 0.06 20.00%
 
NYSE USA Top Losers Stocks
QFTA-WS 0.46 -95.33%
TWND-WS 0.48 -95.12%
CHAA-WS 0.53 -94.56%
PMVC-WS 0.58 -94.10%
PIAI-WS 0.58 -94.09%
PCPC-WS 1.50 -93.83%
FTEV-WS 0.60 -93.81%
PSTH-WS 1.25 -93.65%
PDOT-WS 0.62 -93.65%
CLAA-WS 0.75 -92.26%
 
 
NUVB
Daily Charts		 NUVB
Intraday Charts		 Whats New @
Bazaartrend		 NUVB
Free Analysis
 
NUVB Important Levels Intraday
RESISTANCE1.83
RESISTANCE1.79
RESISTANCE1.76
RESISTANCE1.74
SUPPORT1.66
SUPPORT1.64
SUPPORT1.61
SUPPORT1.57
 
NUVB Forecast May 2024
Share
4th UP Forecast7.29
3rd UP Forecast5.5
2nd UP Forecast4.39
1st UP Forecast3.28
1st DOWN Forecast0.12
2nd DOWN Forecast-0.99
3rd DOWN Forecast-2.1
4th DOWN Forecast-3.89
 
NUVB Weekly Forecast
4th UP Forecast3.53
3rd UP Forecast2.94
2nd UP Forecast2.58
1st UP Forecast2.22
1st DOWN Forecast1.18
2nd DOWN Forecast0.82
3rd DOWN Forecast0.46
4th DOWN Forecast-0.13
 
NUVB Forecast2024
4th UP Forecast15.86
3rd UP Forecast11.32
2nd UP Forecast8.51
1st UP Forecast5.71
1st DOWN Forecast-2.31
2nd DOWN Forecast-5.11
3rd DOWN Forecast-7.92
4th DOWN Forecast-12.46
 
 
NUVB Other Details
Segment EQ
Market Capital 1992494848.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
NUVB Address
NUVB
 
NUVB Latest News
 
Your Comments and Response on Nuvation Bio Inc
 
NUVB Business Profile
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting CDK2, CDK4, and CDK6. It is also developing NUV-868, a selective inhibitor of the BET family of epigenetic transcriptional regulators; NUV-569, a differentiated selective inhibitor of the Wee1 kinase; NUV-1182, an adenosine receptor inhibitor; and DDC platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to androgen receptor-expressing cancer cells , as well as PARP inhibitor to ER-expressing cancer cells. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was incorporated in 2018 and is headquartered in New York, New York. Address: 1500 Broadway, New York, NY, United States, 10036
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service